Flat in situ carcinoma of the bladder: cytological examination of urine in diagnosis, follow up, and assessment of response to chemotherapy.

Urine cytology was performed for the diagnosis and follow up of flat carcinoma in situ (CIS) of the bladder in a series of 35 patients without associated or previous bladder tumours. Ninety six per cent had positive or suspicious cytology at initial presentation. There were no false positive reports. Cytological diagnosis of malignancy was made before biopsy in 24 patients: CIS in voided urine presents as flat sheets of five to 15 cells with features of high grade malignancy. Development of tumour during follow up was suggested by the appearance of large thick sheets and clusters of 30 or more malignant cells which were large and pleomorphic in high grade tumours and relatively small and closely cohesive in low grade tumours. Eleven of 13 patients with these clusters had bladder or ureteric tumours and two had malignant disease in the prostate. Negative cytological results in the presence of degenerative changes caused by chemotherapy was an unreliable indicator of response to chemotherapy, and there were five patients with false negative reports during treatment, of whom three had developed tumour. Persistence of malignant cells with features similar to those seen in the urine before treatment reliably predicted failure to respond to chemotherapy.

[1]  I. Fukui,et al.  Carcinoma in situ of the urinary bladder. Effect of associated neoplastic lesions on clinical course and treatment , 1987, Cancer.

[2]  M. Boon,et al.  Carcinoma in situ of the urinary bladder. Clinical presentation, cytologic pattern and stromal changes. , 1986, Acta cytologica.

[3]  M. Soloway,et al.  Prognostic significance of urine cytology on initial follow‐up after intravesical mitomycin C for superficial bladder cancer , 1986, Cancer.

[4]  R. Weinstein,et al.  Pathology of superficial bladder cancer with emphasis on carcinoma in situ. , 1986, Urology.

[5]  W M Murphy,et al.  Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms , 1984, Cancer.

[6]  G. Prout,et al.  Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms , 1983, Cancer.

[7]  R. Nelson New concepts in staging and follow-up of bladder carcinoma. , 1983, Urology.

[8]  B. Peterson,et al.  Cytologic effects of Thiotepa and Adriamycin on normal canine urothelium. , 1980, Acta cytologica.

[9]  L. Geisse,et al.  Pre-clinical cytological diagnosis of bladder cancer. , 1978, The Journal of urology.

[10]  G. Farrow,et al.  Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. , 1977, Cancer research.

[11]  G. Prout,et al.  Positive urinary cytology in patients without evident tumor. , 1977, The Journal of urology.

[12]  W. Murphy,et al.  Cytology in the diagnosis and followup of transitional cell carcinoma of the urothelium: a review with a case series. , 1976, The Journal of urology.

[13]  T. Seemayer,et al.  Cytology of transitional cell carcinoma in situ of urinary bladder with extensive prostatic involvement. , 1976, Urology.

[14]  L. Koss,et al.  Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man , 1964, Cancer.

[15]  M. Melamed,et al.  Cytology of in situ carcinoma of the human urinary bladder , 1963, Cancer.